SCHEMBL7145484

SCHEMBL7145484

O=C1c2ccccc2-c2[nH]nc(-c3ccc(F)cc3)c21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 15/20 0.68
CCND1 P24385 14/20 0.68
CDK2 P24941 12/20 0.68
CCNE2 O96020 11/20 0.68
CCNE1 P24864 11/20 0.68
USP1 O94782 1/20 0.47
USP19 O94966 1/20 0.47
UCHL3 P15374 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
MAOB P27338 1/20 0.46
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
ALPL P05186 1/20 0.44
MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090159 0.87 CDK4 (0.71) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7146443 0.85 CDK4 (0.68) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL4816704 0.85 CDK4 (0.68) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7148608 0.83 CDK4 (0.66) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7091188 0.77 CCNE2 (0.69) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7140772 0.75 CDK4 (0.70) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL12856433 0.74 CDK2 (0.55) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7093050 0.74 CCNE1 (0.55) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL20035506 0.73 ALDH1A1 (0.53) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7147568 0.72 CDK4 (0.67) CDK4CCND1CDK2CCNE2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534655-B1 Administering as anti-angiogenic compounds or to inhibit vascular hyperpermeability BASF AKTIENGESELLSCHAFT (DE) 2003-03-18 US disclosed
EP-1021182-A1 INDENO[1,2-C] PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY BASF AKTIENGESELLSCHAFT (DE) 2000-07-26 EP disclosed
WO-1999017770-A1 INDENO[1,2-C]PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY BASF AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed